MARTINI, Maurizio
 Distribuzione geografica
Continente #
EU - Europa 5.774
NA - Nord America 4.630
AS - Asia 4.372
SA - Sud America 1.512
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 16.439
Nazione #
US - Stati Uniti d'America 4.494
RU - Federazione Russa 3.447
SG - Singapore 2.234
BR - Brasile 1.307
CN - Cina 817
IT - Italia 642
IE - Irlanda 551
HK - Hong Kong 544
SE - Svezia 335
VN - Vietnam 229
FR - Francia 182
DE - Germania 167
IN - India 82
PL - Polonia 79
BD - Bangladesh 75
GB - Regno Unito 71
AT - Austria 69
ID - Indonesia 69
AR - Argentina 66
NL - Olanda 66
FI - Finlandia 58
CA - Canada 55
MX - Messico 49
TR - Turchia 43
ZA - Sudafrica 43
IQ - Iraq 38
EC - Ecuador 31
TH - Thailandia 30
VE - Venezuela 30
CO - Colombia 29
JP - Giappone 27
UZ - Uzbekistan 27
MA - Marocco 26
UA - Ucraina 24
TN - Tunisia 23
PK - Pakistan 19
KE - Kenya 15
PY - Paraguay 15
PE - Perù 14
ES - Italia 13
JO - Giordania 12
AZ - Azerbaigian 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 9
EG - Egitto 9
KZ - Kazakistan 9
OM - Oman 9
PH - Filippine 9
UY - Uruguay 9
AL - Albania 8
KG - Kirghizistan 8
BG - Bulgaria 7
BH - Bahrain 7
JM - Giamaica 7
CL - Cile 6
RO - Romania 6
RS - Serbia 6
GE - Georgia 5
IL - Israele 5
LB - Libano 5
LT - Lituania 5
NP - Nepal 5
SN - Senegal 5
TW - Taiwan 5
AO - Angola 4
BE - Belgio 4
BN - Brunei Darussalam 4
DO - Repubblica Dominicana 4
NI - Nicaragua 4
NO - Norvegia 4
PS - Palestinian Territory 4
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
MD - Moldavia 3
MY - Malesia 3
PA - Panama 3
PR - Porto Rico 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
DK - Danimarca 2
ET - Etiopia 2
LK - Sri Lanka 2
MU - Mauritius 2
NG - Nigeria 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CG - Congo 1
Totale 16.425
Città #
Moscow 1.143
Ashburn 1.080
Singapore 762
Dublin 551
Hong Kong 537
San Jose 471
Dallas 390
Nyköping 296
Chandler 257
Princeton 240
Medford 204
Messina 201
Beijing 149
The Dalles 134
Lauterbourg 125
Los Angeles 119
São Paulo 102
Council Bluffs 97
Buffalo 76
Warsaw 71
Ho Chi Minh City 64
Guangzhou 61
Jakarta 58
Munich 57
Santa Clara 56
Redondo Beach 53
Frankfurt am Main 50
Hanoi 46
Rome 46
New York 45
Belo Horizonte 42
Nuremberg 41
Rio de Janeiro 37
Milan 35
Vienna 35
Amsterdam 34
Orem 34
Bangkok 29
Montreal 28
Tianjin 28
Brasília 26
Johannesburg 26
Stockholm 26
Tashkent 26
Porto Alegre 25
Shanghai 25
Turku 25
Des Moines 24
Catania 23
Chennai 23
Tokyo 23
Atlanta 22
Lappeenranta 22
Brooklyn 21
San Francisco 20
Denver 19
London 19
Mexico City 19
Chicago 18
Curitiba 17
Xi'an 17
Salvador 15
Shenzhen 15
Campo Grande 14
Manchester 14
Quito 13
Seattle 13
São José dos Campos 13
Baghdad 12
Boston 12
Dong Ket 12
Nairobi 12
Paris 12
Phoenix 12
Santo André 12
Amman 11
Ankara 11
Baku 11
Campinas 11
Helsinki 11
Abidjan 10
Florence 10
Fortaleza 10
Guarulhos 10
Houston 10
Lima 10
Mumbai 10
Pelotas 10
Sumaré 10
Xiamen 10
Casablanca 9
Caxias do Sul 9
Goiânia 9
Istanbul 9
Joinville 9
Miami 9
Palermo 9
Ribeirão Preto 9
Sousse 9
Toronto 9
Totale 8.776
Nome #
Aggressive variants of follicular cell-derived thyroid carcinoma: an overview 195
Overexpression of PRV-1 gene in polycythemia rubra vera and essential thrombocythemia 193
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas 177
Short communication: proangiogenic hematopoietic cells in acute HIV infection 176
Mutations of the BIK gene in human peripheral B-cell lymphomas 176
A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas 172
A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration 159
Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents 157
Histologic Evaluation of Thyroid Nodules Treated with Thermal Ablation: An Institutional Experience 154
Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study 147
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 140
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism 138
Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives 137
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors 134
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience. 133
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 132
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 132
Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas 131
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples 130
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 126
The Simultaneous Use of Bladder Epicheck® and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional Cohort 126
The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features 122
The minefield of indeterminate thyroid nodules: could artificial intelligence be a suitable diagnostic tool? 115
Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneity through the prognostic role of CXCR4 and BRAF analysis 114
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: new insights 113
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 112
A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular Insights 112
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 111
The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology 110
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 109
Morphological features that can predict BRAFV600E -mutated carcinoma in paediatric thyroid cytology 107
ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature 107
Rare histotypes of epithelial biliary tract tumors: A literature review 107
First-line ICIs in renal cell carcinoma 106
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy 105
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group 105
A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ 104
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 103
Immunoexpression of autophagy‑related proteins in a single‑center series of sporadic adult conventional clival chordomas 101
The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation 101
Pilocytic astrocytoma: The paradigmatic entity in low‑grade gliomas (Review) 101
null 100
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 100
Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation 100
A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants 100
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 98
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 98
DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis 97
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 96
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 96
Cuproptosis: A Review on Mechanisms, Role in Solid and Hematological Tumors, and Association with Viral Infections 96
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study) 95
The Role of Cytology in the Diagnosis of Subcentimeter Thyroid Lesions 94
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 94
Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization 93
Telomerase inhibition in malignant gliomas: a systematic review 93
PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker 93
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 93
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 92
Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study 92
The role of fine-needle aspiration in the thyroid nodules of elderly patients 92
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 91
Biomarkers of response to advanced prostate cancer therapy 91
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 91
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 91
Fusobacterium nucleatum and Gastric Cancer: An Emerging Connection 90
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 89
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 89
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma 88
Aseptic Loosening in Total Hip Arthroplasty: Pathophysiology, Biomarkers, and Preventive Treatment Strategies 88
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 88
Morphology combined with ancillary techniques: an algorithm approach for thyroid nodules 88
Methylation study of the Paris system for reporting urinary (TPS) categories 88
Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood-Brain Barrier 87
Absence of structural mutations of the BAK gene in B cell lymphomas 86
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 85
Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillance 85
Bleeding "sarcomatosis" as a rare presentation of vascular graft-related angiosarcoma: case report and review of the literature 85
Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker 84
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes 83
Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples 82
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 82
Molecular testing in EBUS-TBNA specimens of lung adenocarcinoma: a study of concordance between cell block method and liquid-based cytology in appraising sample cellularity and EGFR mutations 82
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 81
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 81
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 81
Neuroimages and Neuropathology of a Stroke-Like Cerebral Lymphomatoid Granulomatosis 80
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 80
The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience 80
Is thyroid gland only a "land" for primary malignancies? Role of morphology and immunocytochemistry 80
BRAF (V600E) MUTATION ANALYSIS ON LBC-PROCESSED ASPIRATION BIOPSIES PREDICTS BILATERALITY AND NODAL INVOLVEMENT IN PAPILLARY THYROID MICROCARCINOMA 80
To obtain more with less: cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 80
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study 80
Targeting the tumor microenvironment in triple-negative breast cancer: Biological insights and therapeutic opportunities 79
PD-L1 expression in prostate cancer and Gleason Grade Group: Is there any relationship? Findings from a multi-institutional cohort 78
How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis 78
The potential of liquid-based cytology in lymph node cytological evaluation: the role of morphology and the aid of ancillary techniques 78
Understanding Neovascularization in Glioblastoma: Insights from the Current Literature 78
The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models 78
Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells 77
Totale 10.504
Categoria #
all - tutte 60.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/2022533 0 3 0 1 10 3 12 6 2 1 11 484
2022/20231.561 248 111 78 63 50 133 46 66 643 19 26 78
2023/2024693 25 55 24 68 20 27 6 32 168 108 21 139
2024/20254.228 44 34 67 192 252 124 308 676 824 198 636 873
2025/20269.699 357 568 613 573 832 1.935 1.357 1.088 1.248 625 398 105
Totale 16.834